Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia ; volume:35 ; number:10 ; day:6 ; month:9 ; year:2018 ; pages:1713-1728 ; date:10.2018
Advances in therapy ; 35, Heft 10 (6.9.2018), 1713-1728, 10.2018
- Urheber
-
Růžičková, Olga
- Beteiligte Personen und Organisationen
-
Killinger, Zdenko
Kasalický, Petr
Hamilton, Lisa
Tyl, Roman
Tomková, Soňa
Kalouche-Khalil, Lama
SpringerLink (Online service)
- DOI
-
10.1007/s12325-018-0779-9
- URN
-
urn:nbn:de:101:1-2018111015315270494811
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Růžičková, Olga
- Killinger, Zdenko
- Kasalický, Petr
- Hamilton, Lisa
- Tyl, Roman
- Tomková, Soňa
- Kalouche-Khalil, Lama
- SpringerLink (Online service)
Ähnliche Objekte (12)
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Postmenopausal osteoporosis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Interleukin-33 serum levels in postmenopausal women with osteoporosis
Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice
Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Postmenopausal osteoporosis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Interleukin-33 serum levels in postmenopausal women with osteoporosis
Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice
Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Postmenopausal osteoporosis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Interleukin-33 serum levels in postmenopausal women with osteoporosis
Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice